Table I.
Characteristics | N | % |
---|---|---|
Age (years) | ||
<65 | 16 | 2.6 |
65 – 74 | 160 | 26.2 |
75 – 84 | 318 | 52.1 |
85+ | 116 | 19.0 |
Sex | ||
Male | 347 | 56.9 |
Female | 263 | 43.1 |
Race | ||
White | 557 | 91.3 |
Black | 17 | 2.8 |
Other | 36 | 5.9 |
MDS risk category | ||
Low-risk | 170 | 27.9 |
High-risk | 153 | 25.1 |
Risk not specified | 287 | 47.1 |
Comorbidities | ||
Congestive heart failure | 87 | 14.3 |
Ischemic heart disease | 218 | 35.7 |
Peripheral vascular disease | 39 | 6.4 |
Cerebrovascular disease | 30 | 4.9 |
Myocardial infarction | 32 | 5.3 |
Diabetes or diabetes with complications | 107 | 17.5 |
Chronic obstructive pulmonary disease | 121 | 19.8 |
Rheumatologic disease | 20 | 3.3 |
Depression or schizophrenia | 38 | 6.2 |
Alzheimer’s disease | 30 | 4.9 |
Ulcer | 15 | 2.5 |
Low-risk (RA, RARS, RCMD, 5q del); High-risk (RAEB); Risk not specified (Therapy-related MDS and MDS, NOS)